{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:56Z","timestamp":1787003756182,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The manifestations and progression of alcohol use disorder (AUD) are influenced by a number of contextual factors, with the current coronavirus pandemic being a significant example. This pandemic has profoundly impacted nearly all aspects of human life and has, therefore, strongly influenced patients suffering from AUD. In some cases, the pandemic has led to a reduction in severity, while in others, it has had the opposite effect. In our own work we have been investigating the negative impact of the pandemic on 45 patients with AUD who were undergoing outpatient treatment, including supervised use of disulfiram (Antabuse), in a close-knit program. A linear trend analysis demonstrated significant alterations in the retention rate over a 3-year period, encompassing the pre-pandemic, pandemic, and post-pandemic periods. During the pandemic the number of treatment cancellations virtually increased. Following the pandemic, a tendency towards the normalization of patient numbers was observed. Our data indicate a high level of vulnerability among patients with severe AUD and highlight a need for the development of alternative, possibly telemedical, treatment methods.<\/jats:p>","DOI":"10.1038\/s41598-025-90081-5","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T04:38:05Z","timestamp":1739767085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Covid-19 pandemic on trajectories of patients with severe alcohol use disorder treated with disulfiram"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4323-3309","authenticated-orcid":false,"given":"Maximilian","family":"Pilhatsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7472-9649","authenticated-orcid":false,"given":"Max","family":"Schallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-3874","authenticated-orcid":false,"given":"Diana","family":"Vogel-Blaschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana-Berenike","family":"Treu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4163-9014","authenticated-orcid":false,"given":"Johannes","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8436-8520","authenticated-orcid":false,"given":"Maik","family":"Spreer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"90081_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000527542","volume":"29","author":"RM Pavarin","year":"2023","unstructured":"Pavarin, R. M. et al. COVID-19-related death in patients with alcohol or substance use disorders. Eur. Addict. Res. 29, 67\u201370 (2023).","journal-title":"Eur. Addict. Res."},{"key":"90081_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/acer.14981","volume":"47","author":"MM Friske","year":"2023","unstructured":"Friske, M. M. et al. Chronic alcohol intake regulates expression of SARS-CoV2 infection-relevant genes in an organ-specific manner. Alcohol Clin. Exp. Res. 47, 76\u201386 (2023).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"90081_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/acer.15041","volume":"47","author":"MM Friske","year":"2023","unstructured":"Friske, M. M. & Spanagel, R. Chronic alcohol consumption and COVID-19 infection risk: A narrative review. Alcohol Clin. Exp. Res. 47, 629\u2013639 (2023).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"90081_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/adb0000796","volume":"36","author":"SF Acuff","year":"2022","unstructured":"Acuff, S. F., Strickland, J. C., Tucker, J. A. & Murphy, J. G. Changes in alcohol use during COVID-19 and associations with contextual and individual difference variables: A systematic review and meta-analysis. Psychol. Addict. Behav. 36, 1\u201319 (2022).","journal-title":"Psychol. Addict. Behav."},{"key":"90081_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.24641","volume":"5","author":"F Deeken","year":"2022","unstructured":"Deeken, F. et al. Patterns of alcohol consumption among individuals with alcohol use disorder during the COVID-19 pandemic and lockdowns in Germany. JAMA Netw. Open 5, e2224641 (2022).","journal-title":"JAMA Netw. Open"},{"key":"90081_CR6","doi-asserted-by":"publisher","first-page":"1110435","DOI":"10.3389\/fpubh.2023.1110435","volume":"11","author":"F Fortinguerra","year":"2023","unstructured":"Fortinguerra, F., Pierantozzi, A. & Trotta, F. The use of medications approved for alcohol use disorders in Italy. Front. Public Health 11, 1110435 (2023).","journal-title":"Front. Public Health"},{"key":"90081_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/01.jcp.0000222512.25649.08","volume":"26","author":"JJ Suh","year":"2006","unstructured":"Suh, J. J., Pettinati, H. M., Kampman, K. M. & O\u2019Brien, C. P. The status of disulfiram: A half of a century later. J. Clin. Psychopharmacol. 26, 290\u2013302 (2006).","journal-title":"J. Clin. Psychopharmacol."},{"key":"90081_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087366","volume":"9","author":"MD Skinner","year":"2014","unstructured":"Skinner, M. D., Lahmek, P., Pham, H. & Aubin, H.-J. Disulfiram efficacy in the treatment of alcohol dependence: A meta-analysis. PLoS ONE 9, e87366 (2014).","journal-title":"PLoS ONE"},{"key":"90081_CR9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/j.1530-0277.2011.01523.x","volume":"35","author":"CH J\u00f8rgensen","year":"2011","unstructured":"J\u00f8rgensen, C. H., Pedersen, B. & T\u00f8nnesen, H. The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin. Exp. Res. 35, 1749\u20131758 (2011).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"90081_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","volume":"311","author":"DE Jonas","year":"2014","unstructured":"Jonas, D. E. et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis. JAMA 311, 1889\u20131900 (2014).","journal-title":"JAMA"},{"key":"90081_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1929","volume":"31","author":"D Dacosta-S\u00e1nchez","year":"2022","unstructured":"Dacosta-S\u00e1nchez, D., Gonz\u00e1lez-Ponce, B. M., Fern\u00e1ndez-Calder\u00f3n, F., S\u00e1nchez-Garc\u00eda, M. & Lozano, O. M. Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real-world data. Int. J. Methods Psychiatr. Res. 31, e1929 (2022).","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"90081_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.addbeh.2005.05.013","volume":"31","author":"SA Ball","year":"2006","unstructured":"Ball, S. A., Carroll, K. M., Canning-Ball, M. & Rounsaville, B. J. Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation. Addict. Behav. 31, 320\u2013330 (2006).","journal-title":"Addict. Behav."},{"key":"90081_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00115-021-01068-2","volume":"92","author":"S Liu","year":"2021","unstructured":"Liu, S., Heinz, A., Haucke, M. N. & Heinzel, S. Globale auswirkungen der COVID-19-pandemie auf die versorgung von Menschen mit psychischen Erkrankungen. Nervenarzt 92, 556\u2013561 (2021).","journal-title":"Nervenarzt"},{"key":"90081_CR14","unstructured":"Landesbetrieb IT.NRW Statistik und IT-Dienstleistungen. NRW: \u00dcber 70 Prozent der alkoholbedingten Krankenhausbehandlungen und Sterbef\u00e4lle betrafen 2021 M\u00e4nner. https:\/\/www.it.nrw\/nrw-ueber-70-prozent-der-alkoholbedingten-krankenhausbehandlungen-und-sterbefaelle-betrafen-2021 (2023)."},{"key":"90081_CR15","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.4103\/ijph.IJPH_465_20","volume":"64","author":"YPS Balhara","year":"2020","unstructured":"Balhara, Y. P. S., Kattula, D., Singh, S., Chukkali, S. & Bhargava, R. Impact of lockdown following COVID-19 on the gaming behavior of college students. Indian J. Public Health 64, S172\u2013S176 (2020).","journal-title":"Indian J. Public Health"},{"key":"90081_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s40359-022-00965-8","volume":"10","author":"H Schecke","year":"2022","unstructured":"Schecke, H., Bohn, A., Scherbaum, N. & Mette, C. Alcohol use during COVID-19 pandemic on the long run: Findings from a longitudinal study in Germany. BMC Psychol. 10, 266 (2022).","journal-title":"BMC Psychol."},{"key":"90081_CR17","unstructured":"BARMER. BARMER-Analyse: Rund 1,5 Millionen Menschen alkoholabh\u00e4ngig|BARMER. https:\/\/www.barmer.de\/presse\/presseinformationen\/pressearchiv\/barmer-analyse-rund-1-5-millionen-menschen-alkoholabhaengig-1251732 (2024)."},{"key":"90081_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/ADM.0000000000000666","volume":"15","author":"A Leibowitz","year":"2021","unstructured":"Leibowitz, A. et al. A telemedicine approach to increase treatment of alcohol use disorder in primary care: A pilot feasibility study. J. Addict. Med. 15, 27\u201333 (2021).","journal-title":"J. Addict. Med."},{"key":"90081_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13419","volume":"29","author":"R Spanagel","year":"2024","unstructured":"Spanagel, R. et al. The ReCoDe addiction research consortium: Losing and regaining control over drug intake-Findings and future perspectives. Addict. Biol. 29, e13419 (2024).","journal-title":"Addict. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90081-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90081-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90081-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T04:38:08Z","timestamp":1739767088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90081-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90081"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90081-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethics committee of the TU Dresden (reference number BO-EK-188052024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"5713"}}